First case of rare blood-clotting condition linked to J&J vaccine diagnosed in Utah – KSL.com
SALT LAKE CITY — The first case of a rare blood-clotting condition thought to be linked to the Johnson & Johnson COVID-19 vaccine has been diagnosed in Utah.
A male patient was recently diagnosed with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials said in a Wednesday news release.
The patient, who is under the age of 50, was treated and is now recovering at home, according to Dr. Yazan Abou-Ismail, an assistant professor of medicine in the Division of Hematology at the University of Utah.
"He continues to do well and feel well," Abou-Ismail said at a Wednesday news conference about the case.
The blood clot condition led to a nationwide pause on administration of the Johnson & Johnson vaccine last month after...